PEAK6 Group’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

PEAK6 Group’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-7,300	Closed	-$301K	–	6038
2015 Q2	$301K	Buy	+7,300	New	+$262K	﹤0.01%	3316
2014 Q4	–	Sell	-8,500	Closed	-$239K	–	5620
2014 Q3	$239K	Sell	8,500 -1,300	-13%	-$39.6K	﹤0.01%	3152
2014 Q2	$296K	Buy	9,800 +7,100	+263%	+$196K	﹤0.01%	2830
2014 Q1	$75K	Buy	2,700 +1,500	+125%	+$39.3K	﹤0.01%	4108
2013 Q4	$31K	Sell	1,200 -8,800	-88%	-$271K	﹤0.01%	4493
2013 Q3	$149K	Buy	10,000 +1,900	+23%	+$52.8K	﹤0.01%	3914
2013 Q2	$233	Buy	+8,100	New	+$223K	﹤0.01%	3487

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

PEAK6 Group's BRLI Position: Q3 2015 in Review

PEAK6 Group sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 9,063 shares — an estimated $374K sold.

PEAK6 Group first reported a position in BRLI in Q2 2015 and held it in 1 quarter. The position peaked at $374K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

PEAK6 Group reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
PEAK6 Group sold 9,063 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $374K.
PEAK6 Group first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2015 and held it in 1 quarter.
PEAK6 Group's BIO-REFERENCE LABS INC-NEW- position peaked at $374K in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on PEAK6 Group's 13F filing for Q3 2015, filed 16 Nov 2015.